BNP Paribas Financial Markets’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$987K Buy
7,183
+2,746
+62% +$377K ﹤0.01% 2209
2025
Q1
$800K Sell
4,437
-3,352
-43% -$604K ﹤0.01% 2159
2024
Q4
$1.22M Sell
7,789
-2,644
-25% -$414K ﹤0.01% 1960
2024
Q3
$1.9M Buy
10,433
+8,098
+347% +$1.47M ﹤0.01% 1451
2024
Q2
$429K Sell
2,335
-14,443
-86% -$2.65M ﹤0.01% 2098
2024
Q1
$2.99M Sell
16,778
-22,294
-57% -$3.97M ﹤0.01% 1310
2023
Q4
$4.85M Buy
39,072
+10,057
+35% +$1.25M 0.01% 983
2023
Q3
$3.37M Buy
29,015
+13,983
+93% +$1.62M ﹤0.01% 1107
2023
Q2
$1.76M Sell
15,032
-10,379
-41% -$1.22M ﹤0.01% 1336
2023
Q1
$2.03M Buy
25,411
+12,607
+98% +$1.01M ﹤0.01% 1324
2022
Q4
$1.01M Sell
12,804
-9,076
-41% -$719K ﹤0.01% 1567
2022
Q3
$1.53M Buy
21,880
+17,303
+378% +$1.21M ﹤0.01% 1596
2022
Q2
$301K Buy
4,577
+2,236
+96% +$147K ﹤0.01% 2297
2022
Q1
$156K Sell
2,341
-3,145
-57% -$209K ﹤0.01% 2646
2021
Q4
$384K Buy
5,486
+1,557
+40% +$109K ﹤0.01% 2517
2021
Q3
$205K Buy
3,929
+3,202
+440% +$167K ﹤0.01% 2447
2021
Q2
$49.4K Sell
727
-1,210
-62% -$82.3K ﹤0.01% 2670
2021
Q1
$149K Buy
1,937
+20
+1% +$1.54K ﹤0.01% 2622
2020
Q4
$115K Sell
1,917
-1,306
-41% -$78.4K ﹤0.01% 2500
2020
Q3
$139K Buy
3,223
+1,675
+108% +$72.1K ﹤0.01% 2335
2020
Q2
$64.1K Sell
1,548
-3,929
-72% -$163K ﹤0.01% 2321
2020
Q1
$237K Buy
5,477
+4,248
+346% +$184K ﹤0.01% 2191
2019
Q4
$68.1K Sell
1,229
-89
-7% -$4.93K ﹤0.01% 2835
2019
Q3
$45.8K Buy
1,318
+1,263
+2,296% +$43.9K ﹤0.01% 2896
2019
Q2
$2.22K Buy
+55
New +$2.22K ﹤0.01% 3685